With the markets hitting fresh highs, should we be celebrating or are we in a market bubble that is getting dangerously big?
Should you invest in the Rs. 960 crore Muthoot Microfin IPO? Find out in this detailed review.
A guide to understanding how regulatory risks can affect your stock investments and few ideas on how you can navigate.
A highly unorganized sector with a huge addressable opportunity and consolidation potential. Play it with this diagnostic stock!
An update on the sugar stock that we have a ‘BUY’ call on in the wake of the curbs placed on manufacture of ethanol in the 23-24 season.
You do need insurance to cover this risk. We think that critical illness policies would be a good choice here. The advantage of buying a critical illness insurance plan is that on diagnosis of a specified serious illness, the insurer pays you a promised lumpsum amount with no questions asked on how you’re planning to spend the money. Critical illness covers are usually offered from a very young age with the age of entry capped at 60 or 65. These policies, however, offer life-long renewability. While many insurers waive medical tests for younger folk, taking such a test can ensure a better claims experience at a later date.
Lofty return expectations can set you up for some rude shocks! Find out how to set your return expectations right in this article.
Wondering where to fit passive equity funds in your portfolio? This article will show you 6 scenarios that are best suited for passive equity funds.
Results update for 4 of our Prime stocks.
The Tata Technologies IPO comes almost 2 decades after the earlier IPO from the Tata group. In this report, you will find out if you should invest in this IPO.
Small Finance Banks have been getting a lot of attention lately. Deep dive into how they have performed and understand what’s behind their success and more.
Hold On
You are being redirected to another page,
Elevate Your Wealth with Professional Portfolio Management
